Efflux pump inhibitors (EPIs) are compounds that interfere with the function of efflux pumps, which are proteins that transport various substances, including drugs, out of cells. In the context of cancer, efflux pumps are often overexpressed, leading to the expulsion of chemotherapeutic agents from cancer cells and contributing to multidrug resistance (MDR).
